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Regarding “Proximalization of the arterial inflow:
a new technique to treat access-related ischemia”
Zanow et al1 have published an important series confirming
the role of proximalization of the arterial inflow (PAI) for
treatment of the steal syndrome. The operation they describe
does not, however, merit the designation “new” (as placed on
the Journal cover, the title, and in Dr Fillinger’s invited com-
mentary)— only its acronym. The authors acknowledge that Dr
Haimov and colleagues2 reported their serendipitous discovery
of the procedure in 1996, but they only speculated on how it
improves distal flow. I described a case with hemodynamic detail
in an article discussing a flow model for various steal treatments3
and commented there and elsewhere4,5 that I use it often to
prevent and treat steal syndromes in both the upper and lower
extremities. Others have also noted that the operation benefits
patients with steal.6 Furthermore, the operation is hemodynam-
ically identical to the distal revascularization interval ligation
(DRIL) procedure, a PAI variant in which the native artery
serves as the proximal half of the loop and the conduit used for
distal revascularization (DR) serves as the inflow for the distal
circulation. In that sense, hundreds of physicians have already
used PAI to treat a steal.
Dr Fillinger’s operation of distal revascularization without
interval ligation (DR without IL), also described previously,3-5 is
technically not PAI, but rather a direct way to improve down-
stream pressure. Nevertheless, all three operations share an impor-
tant clinical feature: namely, the more proximal the anastomosis,
the greater the relief of the steal. They differ in the role of conduit
size: the smaller the interposed conduit for PAI and the larger the
conduit for DR without IL, the more flow to the hand; conduit
size is not important in the DRIL procedure.
One other point warrants comment. The reason PAI and
DRIL work is not because the anastomosis is created on a larger
artery with more capacitance, but rather because, in the reconfig-
ured circuit, flow to the hand originates at a point with higher
pressure (or voltage, if one is using an electrical model).3 This
simple physiological truth suggests that the acronym PAI should
refer not only to the proximalization of the fistula’s origin, but also
to the origin of flow to the distal extremity, because both are
proximalized at the same time. Because the size of the inflow vessel
is immaterial to the success of PAI,3 I have never found it necessary
to proximalize an access to the proximal axillary artery. The distal
axillary artery has served nicely in each instance.
Wayne S. Gradman, MD
Cedars-Sinai Medical Center
Beverly Hills, Calif
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Reply
I respectfully submit that the article by Zanow et al merits
the designation “new.” They have reported the first large series
with the proximilization of arterial inflow (PAI) procedure,
encompassing 30 patients with documentation of mean flow,
digital pressures, and clinical outcomes for multiple different
access combinations over a mean follow-up of 26 months. The
references provided in the letter to the editor include some
innovative work with lower extremity access, banding, and a
very nice theoretical construct expanding on a similar “electrical
circuit” model initially described by David Sumner in 1975.
Despite this, the primary reference to the PAI-type proce-
dure in the letter (Gradman WS, Pozrikidis C. Ann Vasc Surg
2004;18:59-65) is a theoretical construct and the anecdotal
report of a single clinical case with no follow-up. The references
to other authors are for distal revascularization-interval ligation
(DRIL) reports and anecdotal comments on those reports with
no data provided. Thus, the report by Zanow et al is novel and
provides enough clinical information to incorporate into clinical
decision-making.
Regarding other comments, I do not believe the PAI
procedure is “hemodynamically identical to the DRIL proce-
dure.” Yes, there are hemodynamic similarities, as pointed out
in my commentary, but they are clinically quite different, as
there is no arterial ligation, which is the point of the report.
With regard to “distal revascularization without interval liga-
tion,” I made no attempt to state that I invented the procedure.
I only used it to point out similarities in the hemodynamic
concept for an operation I have personally used.
Finally, the hemodynamic explanation in my commentary is
consistent with the “electrical circuit” model for steal. The
letter states “. . . in the reconfigured circuit, flow to the hand
originates at a point with higher pressure.” While a somewhat
confusing way to describe it, flow to the hand could not
“originate at a point with higher pressure” unless there was less
pressure drop across the proximal anastomosis, and this requires
a larger inflow artery better capable of handling the flow, as
described in the commentary.
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We are well aware of the important contributions by Dr Grad-
man showing his experience in the treatment of ischemia after
access construction. The use of the axillary or femoral artery for an
arteriovenous (AV) access in a looped configuration is indeed not
a new procedure. The reports cited in the letter are concerned with
the primary construction of axillary or femoral looped access or
with cases of conversion of prosthetic brachial-axillary access to
a looped configuration, and we referred to them in our article.
Axillary-axillary loop access became a standard in our department
more than 15 years ago and was performed in 142 cases between
1999 and 2005. We repeatedly presented the indications and
results.1,2
In the distal revascularization interval ligation (DRIL) proce-
dure, the distance between the AV anastomosis and the proximal
anastomosis of arterial bypass is only a few centimeters, and the
diameter, ie, the capacity of the artery, and the arterial pressure are
the same at both sites.
However, a significantly larger artery is used in the proximal-
ization of the arterial inflow (PAI) technique. In normal circula-
tion, the pressure drop from the aorta to the arterioles is small
because of a relatively low flow, and the capacity of arteries is
immaterial. An AV access results in a markedly increased flow in the
arteries of the shunt arm and a flow- and diameter-dependent
dissipation of energy. A significant pressure drop occurs if the
capacities of arterialized vein and of peripheral tissue exceed the
capacity of arteries proximal to the anastomosis. The dilatation of
arteries after fistula creation is equated with an increase of capacity
and results in normal arterial pressure proximal to the anastomosis3
and a lower pressure drop distally. Thus, the arterial diameter is an
important hemodynamic factor. The PAI technique can compen-
sate for an inadequate dilatation of calcified arteries and reduces the
arterial pressure drop distal to the anastomosis, respectively.
The size of the conduit determines the access flow and, hence,
the distal arterial pressure in PAI. By contrast, in the DR technique
with or without IL, the bypass works as a large collateral vessel, and
the size of the bypass is immaterial if it is greater than the equivalent
artery.
We lack comprehensive clinical data to prove the necessity of
using the proximal axillary artery as an inflow vessel for PAI. Before
commencing the study, we observed a measurable improvement of
distal perfusion after PAI from the distal to proximal axillary artery
in the three cases. Clinical experience and our considerations about
hemodynamics were the decisive arguments for primary selection
of the proximal axillary arteryin the few cases we reported.
We conclude, therefore, that the PAI technique is a new
systematically applied way with different hemodynamic principles
and provides advantages over the well-establishedDRIL technique
for the treatment of ischemia.
Juergen Zanow, MD
Friedrich Schiller University
Jena, Germany
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Regarding “Carotid endarterectomy in patients
with chronic renal insufficiency: a recent series
of 184 cases”
The Enrico Ascher article from January 2005, “Carotid end-
arterectomy in patients with chronic renal insufficiency: A recent
series of 184 cases,” raised a clinically concerning issue of the high
mortality rate observed in chronic renal insufficiency patients who
undergo carotid endarterectomy (CEA). The author, however,
leaps to a conclusion for a nonoperative approach before other
operative management options have been considered.
All cases in the series were performed with patients under
general anesthesia, which has known inherent cardiac risks, and the
mortalities in the series were believes to be cardiac in origin.
Surgeons who routinely perform CEA with patients under local
regional anesthesia are well aware of the lack of major homody-
namic shifts and the relative stability the patient experiences.
A study needs to be done to compare CEA performed under
local/regional anesthesia vs general anesthesia in patients with
chronic renal insufficiency. Other studies have suggested that
cervical block anesthesia is safer, and this may be the best alterna-
tive to patients with higher cardiac risk factors or, probably, most
patients.
Richard J. Ricca, MD, FACS
Eastern Long Island General and Vascular Surgery, PC
Southhampton, NY
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It is true that all our patients in this study underwent general
anesthesia (GA). Excellent control of the airways and systemic
blood pressure, no pain or anxiety during the procedure, and safe
shunting are some of the advantages offered by GA. The fact that
none of the 443 consecutive patients with normal serum creatinine
died attests to the safety of GA. Additionally, only 1 (0.7%) of 143
patients with serum creatinine between 1.5 and 2.9 mg/dL died.
Conversely, we documented a 17% mortality (4/23 patients) in
the presence of higher serum creatinine levels. We strongly believe
that GA does not contribute significantly to mortality. Since the
published series, we have performed 600 consecutive carotid end-
arterectomies without a single mortality in patients with serum
creatinine less than 3 mg/dL. Yet Dr Ricca’s point is valid because
we do not know the results with regional anesthesia in patients with
very high creatinine levels. On the basis of our results with the
largest series of renal patients undergoing carotid endarterectomy,
we feel that the proposed study is not ethical and will subject
patients to an increased risk of mortality that far outweighs the
benefits of carotid endarterectomy, particularly for asymptomatic
patients. A more reasonable approach for some well-selected pa-
tients may be a balloon angioplasty and stenting of the carotid
artery under local anesthesia.
Enrico Ascher, MD
Maimonides Medical Center
Brooklyn, NY
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